DRCMR Logo 300px Color
 

Add-on MEmaNtine to Dopamine antagonism to improve negative symptoms at first psychosis (AMEND)

  • Funded By: Lundbeckfonden |
  • Total Amount (DKK): 4.999.812 |
  • Grant Year: 2021 |
  • Main Grant Holder: Bjørn Ebdrup |
  • DRCMR PI: Hartwig Siebner |